英国视神经炎发病率与患病率趋势及其与系统性和神经系统疾病的关联
结果显示,ON总体发病率稳定在3.7/10万人年,年点患病率从1997年的69.3/10万上升至2018年的114.8/10万;ON与多发性硬化(MS)关联最强,但也与梅毒、血管炎、结节病等多种IMIDs相关。
要点
- 英国ON发病率22年保持稳定,为3.7/10万人年。
- ON年点患病率从1997年69.3/10万升至2018年114.8/10万。
- ON与MS强烈关联,但也与多种其他IMIDs相关,需警惕并紧急处理以保护视力。
核心结论
- 英国视神经炎发病率稳定,患病率随数据库成熟而上升。
- 视神经炎主要与多发性硬化相关,但也与多种免疫介导炎症性疾病相关,这些关联总数超过MS相关视神经炎,且通常需要紧急管理以保护视力。
研究设计与样本
- 采用年度发病率(1997-2018)和序贯横断面研究估计年点患病率,并开展队列分析探索危险因素,以及匹配病例对照和回顾性队列研究分析66种IMIDs的 antecedent 诊断比值比和 incident 诊断风险比。
主要发现
- 22年总体发病率为3.7(95%CI 3.6-3.9)/10万人年。
- 年点患病率从1997年的69.3(95%CI 57.2-81.3)/10万上升至2018年的114.8(95%CI 111.0-118.6)/10万。
- ON患者既往MS的OR为98.22(95%CI 65.40-147.52),梅毒OR 5.76(95%CI 1.39-23.96),支原体OR 3.90(95%CI 1.09-13.93),血管炎OR 3.70(95%CI 1.68-8.15),结节病OR 2.50(95%CI 1.21-5.18),EB病毒OR 2.29(95%CI 1.80-2.92),克罗恩病OR 1.97(95%CI 1.13-3.43),银屑病OR 1.28(95%CI 1.03-1.58)。
- ON患者发生MS的HR为284.97(95%CI 167.85-483.81),白塞病HR 17.39(95%CI 1.55-195.53),结节病HR 14.80(95%CI 4.86-45.08),血管炎HR 4.89(95%CI 1.82-13.10),干燥综合征HR 3.48(95%CI 1.38-8.76),疱疹病毒感染HR 1.68(95%CI 1.24-2.28)。
- ON发病风险最高的因素包括女性、肥胖、育龄期、吸烟和高纬度居住,南亚或混合种族风险显著低于白人。
关键数值与推荐
- ON总体发病率稳定在3.7/10万人年(95%CI 3.6-3.9)。
- 年点患病率从1997年69.3/10万(95%CI 57.2-81.3)升至2018年114.8/10万(95%CI 111.0-118.6)。
- ON患者既往MS的OR为98.22(95%CI 65.40-147.52),发生MS的HR为284.97(95%CI 167.85-483.81)。
临床怎么用
- 对于视神经炎患者,应评估多发性硬化及其他免疫介导炎症性疾病的可能性。
- 识别女性、肥胖、吸烟等高危因素有助于风险评估。
- 尽管非MS相关IMIDs individual 罕见,但总体数量超过MS相关ON,需紧急管理以保护视力。
局限性
- 研究基于数据库数据,可能存在编码不准确或漏诊。
- 患病率上升可能反映数据库成熟度而非真实疾病负担增加。
- 某些IMIDs的关联估计置信区间较宽,需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Epidemiologic data on optic neuritis (ON) incidence and associations with immune-mediated inflammatory diseases (IMIDs) are sparse. OBJECTIVE: To estimate 22-year trends in ON prevalence and incidence and association with IMIDs in the United Kingdom. DESIGN, SETTING, AND PARTICIPANTS: This cohort study analyzed data from The Health Improvement Network from January 1, 1995, to September 1, 2019. The study included 10 937 511 patients 1 year or older with 75.2 million person-years' follow-up. Annual ON incidence rates were estimated yearly (January 1, 1997, to December 31, 2018), and annual ON prevalence was estimated by performing sequential cross-sectional studies on data collected on January 1 each year for the same period. Data for 1995, 1996, and 2019 were excluded as incomplete. Risk factors for ON were explored in a cohort analysis from January 1, 1997, to December 31, 2018. Matched case-control and retrospective cohort studies were performed using data from January 1, 1995, to September 1, 2019, to explore the odds of antecedent diagnosis and hazard of incident diagnosis of 66 IMIDs in patients compared with controls. EXPOSURES: Optic neuritis. MAIN OUTCOMES AND MEASURES: Annual point prevalence and incidence rates of ON, adjusted incident rate ratios (IRRs) for risk factors, and adjusted odds ratios (ORs) and adjusted hazard ratios (HRs) for 66 IMIDs. RESULTS: A total of 10 937 511 patients (median [IQR] age at cohort entry, 32.6 [18.0-50.4] years; 5 571 282 [50.9%] female) were studied. A total of 1962 of 2826 patients (69.4%) with incident ON were female and 1192 of 1290 92.4%) were White, with a mean (SD) age of 35.6 (15.6) years. Overall incidence across 22 years was stable at 3.7 (95% CI, 3.6-3.9) per 100 000 person-years. Annual point prevalence (per 100 000 population) increased with database maturity, from 69.3 (95% CI, 57.2-81.3) in 1997 to 114.8 (95% CI, 111.0-118.6) in 2018. The highest risk of incident ON was associated with female sex, obesity, reproductive age, smoking, and residence at higher latitude, with significantly lower risk in South Asian or mixed race/ethnicity compared with White people. Patients with ON had significantly higher odds of prior multiple sclerosis (MS) (OR, 98.22; 95% CI, 65.40-147.52), syphilis (OR, 5.76; 95% CI, 1.39-23.96), Mycoplasma (OR, 3.90; 95% CI, 1.09-13.93), vasculitis (OR, 3.70; 95% CI, 1.68-8.15), sarcoidosis (OR, 2.50; 95% CI, 1.21-5.18), Epstein-Barr virus (OR, 2.29; 95% CI, 1.80-2.92), Crohn disease (OR, 1.97; 95% CI, 1.13-3.43), and psoriasis (OR, 1.28; 95% CI, 1.03-1.58). Patients with ON had a significantly higher hazard of incident MS (HR, 284.97; 95% CI, 167.85-483.81), Behçet disease (HR, 17.39; 95% CI, 1.55-195.53), sarcoidosis (HR, 14.80; 95% CI, 4.86-45.08), vasculitis (HR, 4.89; 95% CI, 1.82-13.10), Sjögren syndrome (HR, 3.48; 95% CI, 1.38-8.76), and herpetic infection (HR, 1.68; 95% CI, 1.24-2.28). CONCLUSIONS AND RELEVANCE: The UK incidence of ON is stable. Even though predominantly associated with MS, ON has numerous other associations with IMIDs. Although individually rare, together these associations outnumber MS-associated ON and typically require urgent management to preserve sight.
引用
- Braithwaite T, Subramanian A, Petzold A, et al. Trends in Optic Neuritis Incidence and Prevalence in the UK and Association With Systemic and Neurologic Disease. JAMA Neurol. 2020. PMID: 33017023. doi:10.1001/jamaneurol.2020.3502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。